BioCentury
ARTICLE | Company News

Bioventus, Galderma deal

December 30, 2016 1:40 AM UTC

Galderma granted Bioventus U.S. rights to commercialize Durolane for pain associated with knee osteoarthritis. Bioventus said it plans to submit a PMA to FDA this quarter for the transparent gel conta...